WallStreetZenWallStreetZen

NASDAQ: MDXG
Mimedx Group Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

MDXG past revenue growth

How has MDXG's revenue growth performed historically?
Company
20.03%
Industry
148.4%
Market
16.96%
MDXG's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MDXG's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MDXG's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MDXG earnings and revenue history

Current Revenue
$321.5M
Current Earnings
$58.2M
Current Profit Margin
18.1%

MDXG Return on Equity

Current Company
205.3%
Current Industry
-63.5%
Current Market
188%
MDXG's Return on Equity (205.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MDXG announces earnings.

MDXG Return on Assets

Current Company
30.1%
Current Industry
2.9%
MDXG is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MDXG Return on Capital Employed

Current Company
14.44%
Current Industry
19.5%
MDXG has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MDXG vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MDXG$321.48M$32.57M$58.23M-2.19%N/A
CNTA$6.85M-$165.43M-$151.09MN/AN/A
LQDA$17.49M-$69.65M-$78.50M+45.23%N/A
INVA$310.46M$248.96M$179.72M+3.53%-6.84%
BCYC$26.98M-$169.40M-$180.66M+30.47%N/A
View Top Biotech Stocks

MDXG earnings dates

Next earnings date
Apr 30, 2024

Mimedx Group Earnings & Revenue FAQ

What were MDXG's earnings last quarter?

On Invalid Date, Mimedx Group (NASDAQ: MDXG) reported Q4 2023 earnings per share (EPS) of $0.40, up 2,100% year over year. Total Mimedx Group earnings for the quarter were $58.66 million. In the same quarter last year, Mimedx Group's earnings per share (EPS) was -$0.02.

If you're new to stock investing, here's how to buy Mimedx Group stock.

What was MDXG's earnings growth in the past year?

As of Q2 2024, Mimedx Group's earnings has grown year over year. Mimedx Group's earnings in the past year totalled $58.23 million.

What is MDXG's earnings date?

Mimedx Group's earnings date is Invalid Date. Add MDXG to your watchlist to be reminded of MDXG's next earnings announcement.

What was MDXG's revenue last quarter?

On Invalid Date, Mimedx Group (NASDAQ: MDXG) reported Q4 2023 revenue of $86.83 million up 16.75% year over year. In the same quarter last year, Mimedx Group's revenue was $74.38 million.

What was MDXG's revenue growth in the past year?

As of Q2 2024, Mimedx Group's revenue has grown 20.03% year over year. This is 128.38 percentage points lower than the US Biotechnology industry revenue growth rate of 148.4%. Mimedx Group's revenue in the past year totalled $321.48 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.